MATIGNON TECHNOLOGIES
Matignon Technologies is a euro 50 M closed-end venture capital fund dedicated to investments in unlisted innovative, early-stage companies specialized in high technologies with strong growth potential. The Fund invests as a minority shareholder with a stake comprised between euro 0.5 M and 3.0 M euro. Subscriptions were closed in September 2000 and the Fund has a lifespan of six years.
MATIGNON TECHNOLOGIES
Industry:
Venture Capital
Status:
Active
Contact:
(015)353-0123
Email Addresses:
[email protected]
Technology used in webpage:
SPF Apache Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Java EE OVH Apache Tomcat Coyote OVH DNS
Similar Organizations
Connect Ventures
Connect Ventures is a venture capital firm specialized in investments in seed, startup, series A, and early-stage companies.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2010-09-21 | Arterial Remodeling Technologies | Matignon Technologies investment in Venture Round - Arterial Remodeling Technologies | 8.5 M USD |
| 2010-07-19 | Gentis | Matignon Technologies investment in Venture Round - Gentis | 548.26 K USD |
| 2010-05-05 | Nanobiotix | Matignon Technologies investment in Series C - Nanobiotix | 7 M EUR |
| 2008-10-07 | Orteq | Matignon Technologies investment in Series B - Orteq | 8 M GBP |
| 2007-11-12 | Arterial Remodeling Technologies | Matignon Technologies investment in Venture Round - Arterial Remodeling Technologies | 5.5 M EUR |
| 2007-10-08 | AirInSpace | Matignon Technologies investment in Series B - AirInSpace | 8.5 M USD |
| 2007-06-21 | Gentis | Matignon Technologies investment in Series A - Gentis | 10 M USD |
| 2007-03-30 | GlucoLight | Matignon Technologies investment in Series C - GlucoLight | 2 M USD |
| 2004-07-30 | Alveolus | Matignon Technologies investment in Series B - Alveolus | 10 M USD |